Aspartate aminotransferase and alanine aminotransferase serum activities in neonatal transient myocardial ischemia. 1988

V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
Dipartimento di Pediatria, Università di Padova, Italia.

The behavior of serum aspartate aminotransferase and alanine aminotransferase was evaluated during the first 30 postnatal days in 16 neonates with clinical, electrocardiographic and echocardiographic features of transient myocardial ischemia. These common laboratory tests, requested usually as an aid to diagnosis and surveillance of myocardial damage both in the adult and infant age groups, do not seem to have any value in the perinatal period compared to established reference values of healthy or asphyxiated controls.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007235 Infant, Premature, Diseases Diseases that occur in PREMATURE INFANTS.
D008297 Male Males
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic

Related Publications

V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
January 1987, Padiatrie und Padologie,
V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
January 1982, Enzyme,
V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
September 1983, The Journal of laboratory and clinical medicine,
V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
June 1985, Clinica chimica acta; international journal of clinical chemistry,
V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
January 1974, Clinical chemistry,
V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
December 2008, Neuroscience letters,
V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
January 1990, Acta physiologica Polonica,
V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
January 2015, International journal of clinical and experimental medicine,
V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
November 2004, Nihon rinsho. Japanese journal of clinical medicine,
V Zanardo, and L Vispi, and L Rizzo, and H Cittar, and P A Pellegrino
February 1995, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!